IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Schizo Affective Disorder
Uppsala University Hospitalmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
30 Active assets in the Schizo Affective Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Paliperidone Palmitate 3-Month Formulation Luye Pharma Group Ltd. | Phase 4 | BBB |
Seroquel® Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 4 | BBB |
Lurasidone University of Texas Southwestern Medical Center | Phase 4 | BBB |
Bxcl501 BioXcel Therapeutics Inc | Phase 4 | BBB |
Olanzapine The Royal Ottawa Mental Health Centre | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →